SNHG1 overexpression apparently inhibited osteogenic differentiation, which was indicated by the downregulated osteogenic marker genes osterix (Osx), osteocalcin (OCN), and ALP both protein and mRNA levels after OM treatment (Fig. 2b, c). This evidence concerns the gene SNHG1 and ocular melanoma.